Pixium Vision

IPO

Pixium | Science Corporation

Paris, France · Founded 2011 · $19.3M raised

Headquarters
Paris
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$19.3M
Last Round
$19.3M Series AJul 2023
Rounds
2

About

Pixium Vision was a French medical device company founded in 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie in Paris. The company developed bionic vision systems — most notably the PRIMA subretinal implant — designed to restore partial sight in patients blinded by late-stage retinal degenerative diseases such as dry age-related macular degeneration. Pixium conducted clinical trials in Europe across multiple countries. In 2024, the company went bankrupt and its assets, including ongoing PRIMA clinical trials, were acquired by Science Corporation.

Summary

Pixium Vision is a Biotech company based in Paris, France, founded in 2011. It has raised $19.3M in total across 2 rounds, most recently a $19.3M Series A round in Jul 2023. Investors include Sofinnova Partners and Bpifrance.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

BridgeBridge RoundJul 2023

Sign up to see all 3 rounds

Series A through Bridge — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Pixium Vision on Indexed.vc
<a href="https://indexed.vc/companies/pixium-vision"><img src="https://indexed.vc/api/badge/company/pixium-vision" alt="Pixium Vision on Indexed.vc" width="260" height="76" /></a>